Author: Michelle Sommer

Experimentica’s sites have gained CIR accreditation for 2026-2028, enabling eligible French companies to benefit from CIR-covered preclinical ophthalmic research services. Experimentica’s Kuopio and Vilnius sites are now both CIR-accredited for 2026–2028. Our Kuopio site has held the accreditation since 2020, and with the addition of our Vilnius site, French biotech and pharmaceutical companies can access […]

In her doctoral thesis at the German Cancer Research Center (DKFZ), Mariam Amghar investigated why some prostate cancer patients respond to radioactive drugs while others do not. Her findings may help tailor treatment more effectively to individual patients in the future. Mariam Amghar has been awarded the Helmholtz Doctoral Prize in the “Health” category. At […]

Mirco Julian Friedrich, a physician and cancer researcher at the German Cancer Research Center (DKFZ), the HI-STEM* Stem Cell Research Institute, and Heidelberg University Hospital (UKHD), is being honored for his outstanding research on the aging immune system and the immune response to blood cancer. Mirco Friedrich leads a junior research group at the DKFZ […]

A team led by researchers at the German Cancer Research Center (DKFZ) shows that the WHO’s updated physical activity recommendations fundamentally change the assessment of physical endurance activity. While only 35 percent of respondents met the recommended physical activity targets under the previous WHO guidelines, 99 percent did so under the recommendations in effect since […]

Annual awards program recognizes innovation in life sciences and biotechnology worldwide CHICAGO, November 5, 2026 – VectorBuilder, a global leader in gene delivery technologies, today announced it has been named “Overall CGT Solution Provider of the Year” in the sixth annual BioTech Breakthrough Awards, recognizing innovation across the global life sciences and biotechnology industries. VectorBuilder integrates vector […]

High-content imaging (HCI) has utility throughout the entire drug discovery pipeline—from screening compound libraries and studying cell morphometry to monitoring protein localization and assessing toxicology. With recent advances in HCI instrumentation technology and software, it has never been faster to generate data on large numbers of cells, build automated analysis pipelines, and pull insights from […]

Prestigious funding by European Research Council for pioneering biomedical project Prof. Dr. Dominik Niopek, a scientist at the Institute of Pharmacy and Molecular Biotechnology (IPMB) of Heidelberg University, has been awarded an ERC Synergy Grant for a pioneering biomedical research project involving collaboration between teams in Heidelberg, the United Kingdom and the United States. The […]

How can complex spinal tumor surgeries be planned and prepared more effectively in the future? As part of the IntelliSpine-Recon collaborative project, researchers will develop, among other innovations, a digital twin of the spine and a virtual training environment for surgeons. The junior research consortium, coordinated by the Heidelberg Faculty of Medicine at Heidelberg University, […]

EMBL, MOLIT, and the Dieter Schwarz Foundation join forces to accelerate the capacity of this field, using AI and cutting-edge technologies A new public-private partnership is ‘embracing’ ways to expand the capacity of precision medicine by harnessing cutting-edge technologies and artificial intelligence to better understand and improve how we treat disease – even on an […]